Pfizer CEO rules out generic COVID drug Paxlovid for China

Jan. 9 (Reuters) – Pfizer Inc (PFE.N) It’s not in talks with Chinese authorities to license a generic version of its COVID-19 treatment Paxlovid for use there, CEO Albert Bourla said Monday, but it is in discussions about the price of the branded product. Reuters reported on Friday that China is in talks with Pfizer … Read more

Asian stocks weigh China risks, and the yen hit a 6-month high

https://tmsnrt.rs/2zpUAr4 Asian markets recovered early losses, and US inventory futures have been flat The greenback broke under the 130 yen help degree to succeed in a 6-month low International development fears are weighing on oil costs, however gold is rallying SYDNEY (Reuters) – Asian shares recovered from early losses on Tuesday as buyers weighed the … Read more